Kedrion x InstaLILY AI and Innovation Summit

​Spark Innovation. Accelerate Execution.

​As part of NYC Tech Week, Kedrion and InstaLILY AI have curated a half-day AI and Innovation Summit designed to move the BioPharma industry from experimentation to execution.

​The Kedrion x InstaLILY AI & Innovation Summit will showcase how artificial intelligence is operationalized responsibly, at scale, and inside real-world systems.

​​About Kedrion Biopharma:

​Kedrion Biopharma collects and fractionates blood plasma to produce and distribute plasma-derived therapies for rare, ultra-rare, and debilitating conditions like Coagulation and Neurological Disorders, Immunodeficiencies, and Rh sensitization. They employ approximately 5,200 people worldwide and our industrial network includes 68 plasma collection centers in the United States and 8 in the Czech Republic, and 7 production facilities across 5 countries. They are committed to creating a world where science and care know no bounds, partnering with the medical-scientific community, institutions, patient advocacy groups, and research bodies to foster innovation and improve care. Every connection we make impacts someone, somewhere.

​​About InstaLILY AI:

​​InstaLILY AI is a vertical AI platform for the physical economy that enables companies to deploy autonomous AI teammates, called InstaWorkers™, to execute revenue-generating sales, service, and operations workflows inside existing enterprise systems. Powered by InstaBrain™, a shared company brain built from domain-specific small language models, InstaLILY turns institutional knowledge into autonomous execution, without replacing systems of record. One company brain. Many AI teammates.